Therefore, future studies that include targeted deletion of this mechanosensor in preadipocytes and other PVAT cells that take into account sex differences in normotensive and hypertensive animals are required to determine the impact of PIEZO1 on cardiovascular diseases. Here, PIEZO1 is linked to cardiovascular disorder.